TAK1 mediates the collagen-II-dependent induction of the COX-2 gene and PGE2 release in primary human chondrocytes

Connective Tissue Research

Volumn 51, Issue 6, 2010, Pages 452-458

  Klatt, Andreas R ^a   Klinger, Gabriele ^a   Paul Klausch, Brigitte ^a   Renno, Joerg H ^a   Schmidt, Joachim ^b   Malchau, Gebhart ^a   Wielckens, Klaus ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Dreifaltigkeits Krankenhaus   (Germany)

Author keywords

Collagen II; COX 2; Osteoarthritis; PHC; TAK1

Indexed keywords

COLLAGEN TYPE 2; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1;

ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; CYCLOOXIGENASE 2 GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE EXPRESSION; GENE INDUCTION; GENE SILENCING; HUMAN; HUMAN CELL; PROSTAGLANDIN RELEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; MAP KINASE KINASE KINASES; OSTEOARTHRITIS;

EID: 78049414820     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.3109/03008201003668360     Document Type: Article

References (25)

1. Klatt, A.R., Paul-Klausch, B., Klinger, G., Kuhn, G., Renno, J.H., Banerjee, M., Malchau, G., and Wielckens, K. (2009). A critical role for collagen II in cartilage matrix deg-radation: collagen II induces pro-inflammatory cytokines and MMPs in primary human chondrocytes. J. Orthop. Res. 27(1):65-70.
2. Siegle, I., Klein, T., Backman, J.T., Saal, J.G., Nusing, R.M., and Fritz, P. (1998). Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential eleva-tion of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum. 41(1):122-129.
3. Pablos, J.L., Santiago, B., Carreira, P.E., Galindo, M., and Gomez-Reino, J.J. (1999). Cyclooxygenase-1 and-2 are expressed by human T cells. Clin. Exp. Immunol. 115(1): 86-90.
4. Herschman, H.R. (1996). Prostaglandin synthase 2. Biochim. Biophys. Acta 1299(1): 125-140.
5. Willoughby, D.A., Moore, A.R., and Colville-Nash, P.R. (2000). COX-1, COX-2, and COX-3 and the future Treatment of chronic inflammatory disease. Lancet 355(9204): 646-648.
6. Wittenberg, R.H., Willburger, R.E., Kleemeyer, K.S., and Peskar, B.A. (1993). In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases. Arthritis Rheum. 36(10): 1444-1450.
7. Martel-Pelletier, J., Pelletier, J.P., and Fahmi, H. (2003). Cyclooxygenase-2 and prostaglandins in articular tissues. Semin. Arthritis Rheum. 33(3):155-167.
8. Crofford, L.J. (1999). COX-2 in synovial tissues. Osteoarthr. Cartil. 7(4):406-408.
9. Klatt, A.R., Zech, D., Kuhn, G., Paul-Klausch, B., Klinger, G., Renno, J.H., Schmidt, J., Malchau, G., and Wielckens, K. (2009). Discoidin domain receptor 2 mediates the collagen II-dependent release of interleukin-6 in primary human chon-drocytes. J. Pathol. 218(2):241-247.
10. Das, S., Ongusaha, P.P., Yang, Y.S., Park, J.M., Aaronson, S.A., and Lee, S.W. (2006). Discoidin domain receptor 1 receptor tyrosine kinase induces Cyclooxygenase-2 and pro-motes chemoresistance through nuclear factor-κB pathway activation. Cancer Res. 66(16):8123-8130.
11. Moriguchi, T., Kuroyanagi, N., Yamaguchi, K., Gotoh, Y., Irie, K., Kano, T., Shirakabe, K., Muro, Y., Shibuya, H., Matsumoto, K., Nishida, E., and Hagiwara, M. (1996). A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J. Biol. Chem. 271(23): 13675-13679.
12. Shirakabe, K., Yamaguchi, K., Shibuya, H., Irie, K., Matsuda, S., Moriguchi, T., Gotoh, Y., Matsumoto, K., and Nishida, E. (1997). TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase. J. Biol. Chem. 272(13):8141-8144.
13. Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., and Matsumoto, K. (1995). Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270(5244):2008-2011.
14. Matsuyama, W., Faure, M., and Yoshimura, T. (2003). Activation of discoidin domain receptor 1 facilitates the maturation of human monocyte-derived dendritic cells through the TNF receptor associated factor 6/TGF-beta-activated protein kinase 1 binding protein 1 beta/p38 alpha mitogen-activated protein kinase signaling cascade. J. Immunol. 171(7):3520-3532.
15. Vogel, W.F., Abdulhussein, R., and Ford, C.E. (2006). Sens-ing extracellular matrix: an update on discoidin domain receptor function. Cell. Signal. 18(8): 1108-1116.
16. Amin, A.R., Attur, M., Patel, R.N., Thakker, G.D., Marshall, P.J., Rediske, J., Stuchin, S.A., Patel, I.R., and Abramson, S.B. (1997). Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. J. Clin. Invest. 99(6):1231-1237.
17. Crofford, L.J., Wilder, R.L., Ristimaki, A.P., Sano, H., Remmers, E.F., Epps, H.R., and Hla, T. (1994). Cyclooxy-genase-1 and-2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticoster-oids. J. Clin. Invest. 93(3):1095-1101.
18. Mastbergen, S.C., Bijlsma, J.W., and Lafeber, F.P. (2005). Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study. Osteoarthr. Cartil. 13(6):519-526.
19. Tung, J.T., Venta, P.J., Eberhart, S.W., Yuzbasiyan-Gurkan, V., Alexander, L., and Caron, J.P. (2002). Effects of anti-arthri-tis preparations on gene expression and enzyme activity of cyclooxygenase-2 in cultured equine chondrocytes. Am. J. Vet. Res. 63(8):1134-1139.
20. Portanova, J.P., Zhang, Y., Anderson, G.D., Hauser, S.D., Masferrer, J.L., Seibert, K., Gregory, S.A., and Isakson, P.C. (1996). Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J. Exp. Med. 184(3):883-891.
21. McCoy, J.M., Wicks, J.R., and Audoly, L.P. (2002). The role of prostaglandin E2 receptors in the pathogenesis of rheuma-toid arthritis. J. Clin. Invest. 110(5):651-658.
22. Myers, L.K., Kang, A.H., Postlethwaite, A.E., Rosloniec, E.F., Morham, S.G., Shlopov, B.V., Goorha, S., and Ballou, L.R. (2000). The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum. 43(12):2687-2693.
23. Crofford, L.J. (2002). Specific cyclooxygenase-2 inhibitors: what have we learned since they came into widespread clinical use? Curr. Opin. Rheumatol. 14(3):225-230.
24. Klatt, A.R., Klinger, G., Neumuller, O., Eidenmuller, B., Wagner, I., Achenbach, T., Aigner, T., and Bartnik, E. (2006). TAK1 downregulation reduces IL-1beta induced expression of MMP13, MMP1 and TNF-alpha. Biomed. Pharmacother. 60(2):55-61.
25. Ninomiya-Tsuji, J., Kajino, T., Ono, K., Ohtomo, T., Matsumoto, M., Shiina, M., Mihara, M., Tsuchiya, M., and Matsumoto, K. (2003). A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J. Biol. Chem. 278(20):18485-18490.